Effects of combined in vivo treatment of transplantable solid mammary carcinoma in Wistar rats using vitamin E and cysteine peptidase inhibitors from human placenta

Journal of Experimental Therapeutics and Oncology

Volumn 3, Issue 2, 2003, Pages 95-102

  Saleh, Yousif ^a   Siewiñski, Maciej ^a   Sebzda, Tadeusz ^a   Grybos, Marian ^a   Pawelec, Malgorzata ^a   Janocha, Anna ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Cathepsin B; Mammary carcinoma; Placental inhibitor; Vitamin E; Wistar rats

Indexed keywords

ALPHA TOCOPHEROL; ANTINEOPLASTIC AGENT; CATHEPSIN B; CYSTEINE PROTEINASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; BREAST METASTASIS; CANCER SIZE; CANCER SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; ENZYME ACTIVITY; FEMALE; NONHUMAN; PLACENTA; PRIORITY JOURNAL; RAT; RAT STRAIN; SOLID TUMOR; SURVIVAL TIME; TISSUE HOMOGENATE;

ANIMALS; CARCINOMA; CATHEPSIN B; CYSTEINE PROTEINASE INHIBITORS; ENZYME INHIBITORS; FEMALE; HUMANS; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PLACENTA; RATS; RATS, WISTAR; TIME FACTORS; VITAMIN E;

EID: 0038792319     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1359-4117.2003.01077.x     Document Type: Article

References (27)

1. Dormitory NV, Pan RQ, Bauer J, Jones TI. Some aspects of vitamin E related to humans and breast cancer prevention. Adv Exp Med Biol 364: 119-127, 1994.
2. Malafa MP, Neitzel LT. Vitamin E succinate promotes breast cancer tumor dormancy. J Surg Res 93(1): 163-170, 2000.
3. Meyer EC, Sommers DK, Reitz CJ, Mentis H. Vitamin E and benign breast disease. Surgery 107(5): 549-551, 1990.
4. Duffy MJ. The role of proteolytic enzymes in cancer invasion and metastasis. Clin Exp Metastasis 10: 145-155, 1992.
5. Xing R, Wu F, Mason RW. Control of breast tumor cell growth using a targeted cysteine protease inhibitor. Cancer Res 58: 904-909, 1998.
6. Kobayashi H, Gotoh J, Shinohara H, Moniwa N, Terao T. Inhibition of the metastasis of Lewis lung carcinoma by antibody against urokinase-type plasminogen activator in the experimental and spontaneous metastasis model. Thromb Haemost 71: 474-480, 1994.
7. Kobayashi H, Shinohara H, Gotoh J, Fujie M, Fujishiro S, Terao T. Anti-metastatic therapy by urinary trypsin inhibitor in combination with an anti-cancer agent. Br J Cancer 72: 1131-1137, 1995.
8. Saleh Y, Ziólkowski P, Siewiñski M, Milach J, Marszalik P, Rybka J. The combined treatment of transplantable solid mammary carcinoma in Wistar rats by use of photodynamic therapy and cysteine proteinase inhibitor. In Vivo 15: 351-358, 2001.
9. Siewiñski M. Method of purification of thiol proteinase inhibitors from human urine. Cancer Biochem Biophys 12: 33-44, 1991.
10. Bûtzow R, Huhtala ML, Bohn H, Virtanen I, Seppälä M. Purification and characterisation of placenta protein 5. Biochem Biophys Res Commun 150: 483-490, 1988.
11. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
12. Umemoto U, Naito M, Suzuki I, Namikawa I. Growth inhibition of a human oral bacterium Porphyromonas gingivalis by rat cysteine proteinase inhibitor cystatin S. Lett Appl Microbiol 23: 151-153, 1996.
13. Heidtmann HH, Salge U, Abrahamson M, Bencina M, Kasteliv L, Kopitar-Jerala N, Turk V, Lah TT. Cathepsin B and cysteine proteinase inhibitors in human lung cancer cell lines. Clin Exp Metastasis 15: 368-381, 1997.
14. Hoff J, Rlang L. Methods of blood collection in the mouse. Lab Anim Tech 29: 47-53, 2000.
15. Barrett AJ, Kirschke H. Cathepsin B, cathepsin H, and cathepsin L. Methods Enzymol 80: 535-561, 1981.
16. Barrett AJ. Fluorimetric assays for cathepsin B and cathepsin H with methylcoumarylamide substrates. Biochem J 187: 909-912, 1980.
17. Dimitrov NV, Pan RQ, Bauer J, Jones TI. Some aspects of vitamin E related to humans and breast cancer prevention. Adv Exp Med Biol 364: 119-127, 1994.
18. Ambrosone CB, Marshall JR, Vena JE, Laughlin R, Graham S, Nemoto T, Freudenheim JL. Interaction of family history of breast cancer and dietary antioxidants with breast cancer risk (New York, United States). Cancer Causes Control 6: 407-415, 1995.
19. Lah TT, Kos J. Cysteine proteinases in cancer progression and their clinical relevance for prognosis. Biol Chem 379: 125-130, 1998.
20. Lockwood K, Moesgaard S, Hanioka T, Folkers K. Apparent partial remission of breast cancer in 'high risk' patients supplemented with nutritional antioxidants, essential fatty acids and coenzyme Q10. Mol Aspects Med 15: 231-240, 1994.
21. Sakamoto W, Yoshikawa K, Shinadoh M, et al. In vivo effect of vitamin E on peritoneal macrophages and T-kininogen level rats. Int J Vitam Nutr Res 59: 131-139, 1989.
22. Tandon SK, Singh S. Influence of vitamin E on preventive or therapeutic effect of MFA and DTPA in cadmium toxicity. Biomed Environ Sci 8: 59-64, 1995.
23. Gabrijelcic D, Svetic B, Spaic D, et al. Cathepsins B, H, and L in human breast carcinoma. Eur J Clin Chem Clin Biochem 30: 69-74, 1992.
24. Sukoh N, Abe S, Ogura S, Isobe H, Takekawa H, Inoue K, Kawakami Y. Immunohistochemical study of cathepsin B. Prognostic significance in human lung cancer. Cancer 74: 46-51, 1994.
25. Ebert W, Knoch H, Werle B, Trefz G, Muley T, Spiess E. Prognostic value of increased lung tumor tissue cathepsin B. Anticancer Res 14: 895-899, 1994.
26. Murnane MJ, Sheahan K, Ozdemirli M, Shuja S. Stage specific increases in cathepsin B messenger RNA content inhuman colorectal carcinoma. Cancer Res 51: 1137-1142, 1991.
27. Thomssen C, Schmitt M, Goretzki L, Oppelt P, Jänicke F, Pache L, Graeff H. Prognostic values of the cysteine protease cathepsin B and L in human breast cancer. Clin Cancer Res 1: 741-746, 1995.